Abstract
The search for novel neuroprotection strategies in ischemic stroke continues, as revascularization using tissue-plasminogen activator is the only pharmacological method currently available to patients. The purpose of this review article is to summarize research findings regarding the erythropoietin-producing hepatocellular receptor pathway as an emerging novel molecular target for neuroprotection in ischemic stroke. Ephrin–Eph interactions represent a new strategy in neuroprotection. Potential therapeutic targets include the different cellular locations within the neurovascular unit (e.g. astrocytes and neurons) and the different ephrin receptor subtypes. In particular, ephrin-B2/EphB4 receptor stimulation seems to exert neuroprotective effects, while stimulation of other ligands/receptors results in deleterious effects, during the post-ischemic stroke recovery phase. Neuroprotection, assessed by either a decrease in neurovascular unit injury markers or improvement in motor function tests, can be achieved by modulating the activity of different ephrin–Eph receptor subtypes. These novel molecular targets provide multiple potential neuroprotective therapeutic benefits, with meaningful clinical outcomes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arvanitis D, Davy A (2008) Eph/ephrin signaling: networks. Genes Dev 22:416–429. https://doi.org/10.1101/gad.163040822/4/416
Bong YS, Lee HS, Carim-Todd L, Mood K, Nishanian TG, Tessarollo L, Daar IO (2007) ephrinB1 signals from the cell surface to the nucleus by recruitment of STAT3 Proc Natl Acad Sci U S A 104:17305–17310. 0702337104 https://doi.org/10.1073/pnas.0702337104
Chen F et al (2018) Activation of EphA4 induced by EphrinA1 exacerbates disruption of the blood-brain barrier following cerebral ischemia-reperfusion via the rho/ROCK signaling pathway. Exp Therapeut Med 16:2651–2658. https://doi.org/10.3892/etm.2018.6460
Coucha M, Barrett AC, Elgebaly M, Ergul A, Abdelsaid M (2019) Inhibition of Ephrin-B2 in brain pericytes decreases cerebral pathological neovascularization in diabetic rats. PLoS One 14:e0210523. https://doi.org/10.1371/journal.pone.0210523
Doeppner TR et al (2011) Enhancement of endogenous neurogenesis in ephrin-B3 deficient mice after transient focal cerebral ischemia. Acta Neuropathol 122:429–442. https://doi.org/10.1007/s00401-011-0856-5
Eilken HM et al (2017) Pericytes regulate VEGF-induced endothelial sprouting through VEGFR1. Nat Commun 8:1574. https://doi.org/10.1038/s41467-017-01738-3
Ernst AS et al (2019) EphB2-dependent signaling promotes neuronal excitotoxicity and inflammation in the acute phase of ischemic stroke. Acta Neuropathologica Communications 7:15. https://doi.org/10.1186/s40478-019-0669-7
Ghori A, Freimann FB, Nieminen-Kelha M, Kremenetskaia I, Gertz K, Endres M, Vajkoczy P (2017) EphrinB2 activation enhances vascular repair mechanisms and reduces brain swelling after mild cerebral ischemia. Arterioscler Thromb Vasc Biol 37:867–878. https://doi.org/10.1161/ATVBAHA.116.308620
Goldshmit Y, Bourne J (2010) Upregulation of EphA4 on astrocytes potentially mediates astrocytic gliosis after cortical lesion in the marmoset monkey. J Neurotrauma 27:1321–1332. https://doi.org/10.1089/neu.2010.1294
Hilal R et al (2018) Diabetic ephrin-B2-stimulated peripheral blood mononuclear cells enhance poststroke recovery in mice. Stem Cells Int 2018:2431567. https://doi.org/10.1155/2018/2431567
Jin R, Yang G, Li G (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 87:779–789. https://doi.org/10.1189/jlb.1109766jlb.1109766
Khatri R, McKinney AM, Swenson B, Janardhan V (2012) Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke Neurology 79:S52–S57. 79/13_Supplement_1/S52 https://doi.org/10.1212/WNL.0b013e3182697e70
Lemmens R, Jaspers T, Robberecht W, Thijs VN (2013) Modifying expression of EphA4 and its downstream targets improves functional recovery after stroke. Hum Mol Genet 22:2214–2220. https://doi.org/10.1093/hmg/ddt073
Lobov IB et al (2011) The Dll4/notch pathway controls postangiogenic blood vessel remodeling and regression by modulating vasoconstriction and blood flow. Blood 117:6728–6737. https://doi.org/10.1182/blood-2010-08-302067blood-2010-08-302067
Neng L, Zhang F, Kachelmeier A, Shi X (2013) Endothelial cell, pericyte, and perivascular resident macrophage-type melanocyte interactions regulate cochlear intrastrial fluid-blood barrier permeability. J Assoc Res Otolaryngol 14:175–185. https://doi.org/10.1007/s10162-012-0365-9
Overman JJ et al (2012) A role for ephrin-A5 in axonal sprouting, recovery, and activity-dependent plasticity after stroke. Proc Natl Acad Sci U S A 109:E2230–E2239. https://doi.org/10.1073/pnas.1204386109
Pasquale EB (2008) Eph-ephrin bidirectional signaling in physiology and disease. Cell 133:38–52. https://doi.org/10.1016/j.cell.2008.03.011S0092-8674(08)00386-3
Sakamoto A et al (2011) Expression profiling of the ephrin (EFN) and EPH receptor (EPH) family of genes in atherosclerosis-related human cells. J Int Med Res 39:522–527. https://doi.org/10.1177/147323001103900220
Salvucci O, Maric D, Economopoulou M, Sakakibara S, Merlin S, Follenzi A, Tosato G (2009) EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures. Blood 114:1707–1716. https://doi.org/10.1182/blood-2008-12-192294blood-2008-12-192294
Salvucci O et al (2015) EphrinB2 controls vessel pruning through STAT1-JNK3 signalling. Nat Commun 6:6576. https://doi.org/10.1038/ncomms7576
Salvucci O, Tosato G (2012) Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis. Adv Cancer Res 114:21–57. https://doi.org/10.1016/B978-0-12-386503-8.00002-8B978-0-12-386503-8.00002-8
Sawamiphak S, Seidel S, Essmann CL, Wilkinson GA, Pitulescu ME, Acker T, Acker-Palmer A (2010) Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis. Nature 465:487–491. https://doi.org/10.1038/nature08995nature08995
Simonavicius N et al (2012) Pericytes promote selective vessel regression to regulate vascular patterning. Blood 120:1516–1527. https://doi.org/10.1182/blood-2011-01-332338blood-2011-01-332338
Thomas H, Cowin AJ, Mills SJ (2017) The importance of Pericytes in healing: wounds and other pathologies Int J Mol Sci 18:E1129. https://doi.org/10.3390/ijms18061129ijms18061129
Thundyil J et al (2013) Evidence that the EphA2 receptor exacerbates ischemic brain injury. PLoS One 8:e53528. https://doi.org/10.1371/journal.pone.0053528
Wang Y et al (2010) Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465:483–486. https://doi.org/10.1038/nature09002nature09002
Weekman EM, Wilcock DM (2016) Matrix metalloproteinase in blood-brain barrier breakdown in dementia. J Alzheimers Dis 49:893–903. https://doi.org/10.3233/JAD-150759JAD150759
Winkler EA et al (2018) Reductions in brain pericytes are associated with arteriovenous malformation vascular instability. J Neurosurg 129:1464–1474. https://doi.org/10.3171/2017.6.JNS178602017.6.JNS17860
Wu LY, Yu XL, Feng LY (2015) Connexin 43 stabilizes astrocytes in a stroke-like milieu to facilitate neuronal recovery. Acta Pharmacol Sin 36:928–938. https://doi.org/10.1038/aps.2015.39
Yang J, Luo X, Huang X, Ning Q, Xie M, Wang W (2014) Ephrin-A3 reverse signaling regulates hippocampal neuronal damage and astrocytic glutamate transport after transient global ischemia. J Neurochem 131:383–394. https://doi.org/10.1111/jnc.12819
Zhu Y et al (2017) Design and evaluation of EphrinA1 mutants with cerebral protective effect. Sci Rep 7:1881. https://doi.org/10.1038/s41598-017-02091-7
Acknowledgements
Thanks to Dr. M. Abdelsaid RPh/PhD, Mercer University School of Medicine, for providing valuable comments on the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure Statement
None.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Elgebaly, M.M. Ephrin–Eph Signaling as a Novel Neuroprotection Path in Ischemic Stroke. J Mol Neurosci 70, 2001–2006 (2020). https://doi.org/10.1007/s12031-020-01603-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-020-01603-x